Business-friendly Changes Proposed for Revenue Sharing by Stem Cell Agency
The $3 billion California stem cell agency, which hopes to generate income for the state through the sale of stem cell therapies, is moving to make its profit-sharing rules more friendly to business.
The proposed changes will come up Monday morning before the Intellectual Property and Industry Subcommittee of the CIRM governing board.
No stem cell resear…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.